Royal Bank of Canada’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
306,978
+103,218
| +51% | +$3.72M | ﹤0.01% | 1782 |
|
|
2025
Q1 | $6.34M | Buy |
203,760
+160,191
| +368% | +$4.99M | ﹤0.01% | 1862 |
|
|
2024
Q4 | $1.11M | Sell |
43,569
-336,865
| -89% | -$8.59M | ﹤0.01% | 3056 |
|
|
2024
Q3 | $10.8M | Sell |
380,434
-27,652
| -7% | -$782K | ﹤0.01% | 1519 |
|
|
2024
Q2 | $10.8M | Sell |
408,086
-401,921
| -50% | -$10.6M | ﹤0.01% | 1469 |
|
|
2024
Q1 | $24.6M | Buy |
810,007
+316,439
| +64% | +$9.61M | 0.01% | 1034 |
|
|
2023
Q4 | $13.9M | Buy |
493,568
+79,291
| +19% | +$2.23M | ﹤0.01% | 1294 |
|
|
2023
Q3 | $11.2M | Sell |
414,277
-99,621
| -19% | -$2.7M | ﹤0.01% | 1303 |
|
|
2023
Q2 | $15.8M | Buy |
513,898
+142,349
| +38% | +$4.38M | ﹤0.01% | 1154 |
|
|
2023
Q1 | $13.4M | Buy |
371,549
+4,433
| +1% | +$160K | ﹤0.01% | 1216 |
|
|
2022
Q4 | $14.5M | Sell |
367,116
-3,017
| -0.8% | -$119K | ﹤0.01% | 1192 |
|
|
2022
Q3 | $14.9M | Buy |
370,133
+1,641
| +0.4% | +$65.9K | ﹤0.01% | 1104 |
|
|
2022
Q2 | $15.5M | Sell |
368,492
-123,650
| -25% | -$5.2M | ﹤0.01% | 1136 |
|
|
2022
Q1 | $19.2M | Buy |
492,142
+45,430
| +10% | +$1.77M | ﹤0.01% | 1107 |
|
|
2021
Q4 | $17.8M | Buy |
446,712
+23,450
| +6% | +$935K | ﹤0.01% | 1262 |
|
|
2021
Q3 | $15.3M | Buy |
423,262
+68,527
| +19% | +$2.48M | ﹤0.01% | 1345 |
|
|
2021
Q2 | $14.5M | Buy |
354,735
+221,771
| +167% | +$9.09M | ﹤0.01% | 1401 |
|
|
2021
Q1 | $5.8M | Buy |
132,964
+121,406
| +1,050% | +$5.3M | ﹤0.01% | 1869 |
|
|
2020
Q4 | $579K | Buy |
11,558
+4,846
| +72% | +$243K | ﹤0.01% | 3527 |
|
|
2020
Q3 | $284K | Buy |
6,712
+3,225
| +92% | +$136K | ﹤0.01% | 3840 |
|
|
2020
Q2 | $170K | Buy |
+3,487
| New | +$170K | ﹤0.01% | 4101 |
|